Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia

Smits, Evelien L.J.; Lee, Cindy; Hardwick, Nicola; Brooks, Suzanne; Van Tendeloo, Viggo F.I.; Orchard, Kim; Guinn, Barbara Ann

doi:10.1007/s00262-011-1022-6

All Outputs (2)

Expression of CD66 in non-Hodgkin lymphomas and multiple myeloma (2011)
Journal Article
Guinn, B. A., Bosslet, K., Lee, C., Richardson, D., & Orchard, K. (2011). Expression of CD66 in non-Hodgkin lymphomas and multiple myeloma. European Journal of Haematology, 87(6), 554-555. https://doi.org/10.1111/j.1600-0609.2011.01698.x

Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia (2011)
Journal Article
Smits, E. L., Lee, C., Hardwick, N., Brooks, S., Van Tendeloo, V. F., Orchard, K., & Guinn, B. A. (2011). Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia. Cancer Immunology, Immunotherapy, 60(6), 757-769. https://doi.org/10.1007/s00262-011-1022-6

Immunotherapy is currently under active investigation as an adjuvant therapy to improve the overall survival of patients with acute myeloid leukaemia (AML) by eliminating residual leukaemic cells following standard therapy. The graft-versus-leukaemia... Read More about Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia.